FOS and breast cancer: Madeo and Maggiolini [98] revealed that GPER is exclusively expressed as an estrogen receptor in mammary cancer-associated fibroblasts and induces the expression of C-FOS, cyclin D1, and CTGF in response to E2, as confirmed at both the mRNA and the protein levels, resulting in the promotion of proliferation.